The heart & mind trial:intervention with cognitive-behavioural therapy in patients with cardiac disease and anxiety: randomised controlled trial protocol

Autor: Selina Kikkenborg Berg, Charlotte Brun Thorup, Margrethe Herning, Carsten Juul, Signe Stelling Risom, Inge Schjødt, Signe Westh Christensen, Trine Bernholdt Rasmussen, Martin Balslev Jørgensen, Lau Caspar Thygesen, Jesper Hastrup Svendsen
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Berg, S K, Herning, M, Schjødt, I, Thorup, C B, Juul, C, Svendsen, J H, Jorgensen, M B, Risom, S S, Christensen, S W, Thygesen, L & Rasmussen, T B 2021, ' The heart & mind trial : intervention with cognitive-behavioural therapy in patients with cardiac disease and anxiety: randomised controlled trial protocol ', BMJ Open, vol. 11, no. 12, e057085 . https://doi.org/10.1136/bmjopen-2021-057085
BMJ Open, Vol 11, Iss 12 (2021)
Berg, S K, Herning, M, Schjodt, I, Thorup, C B, Juul, C, Svendsen, J H, Jorgensen, M B, Risom, S S, Christensen, S W, Thygesen, L & Rasmussen, T B 2021, ' The heart & mind trial : Intervention with cognitive-behavioural therapy in patients with cardiac disease and anxiety: Randomised controlled trial protocol ', BMJ Open, vol. 11, no. 12, e057085 . https://doi.org/10.1136/bmjopen-2021-057085
BMJ Open
Berg, S K, Herning, M, Schjodt, I, Thorup, C B, Juul, C, Svendsen, J H, Jorgensen, M B, Risom, S S, Christensen, S W, Thygesen, L & Rasmussen, T B 2021, ' The heart & mind trial: intervention with cognitive–behavioural therapy in patients with cardiac disease and anxiety : randomised controlled trial protocol ', BMJ Open, vol. 11, no. 12, e057085 . https://doi.org/10.1136/bmjopen-2021-057085
Popis: IntroductionPatients with cardiac disease often experience anxiety (prevalence about 20%–25%) and have a doubled mortality risk when suffering from anxiety compared with patients without anxiety. This calls for interventions aiming to reduce anxiety.Methods and analysisThe Heart & Mind Trial consists of three parts: (1) screening of all hospitalised and outpatient cardiac patients with arrhythmia, heart failure or ischaemic heart disease at four university hospitals in Denmark using the Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A); Patients scoring ≥8 is invited to participate; (2) Assessment of the type of anxiety by Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders and (3) Randomised clinical superiority trial with blinded outcome assessment, with 1:1 randomisation to cognitive–behavioural therapy (CBT) performed by a CBT-trained cardiac nurse plus usual care or, usual care alone. The primary outcome is anxiety measured with HADS-A at 5 months. Secondary outcomes include anxiety symptoms measured with Becks Anxiety Inventory and heart rate variability. Exploratory outcomes measured at 12 months include blood cortisol (stress response), blood C reactive protein (stress response), health-related quality of life, readmission, mortality and attributable direct costs. A total of 336 patients will be included. The primary analyses are based on the intention-to-treat principle. For the primary outcome, we will use a linear regression model. For the long-term outcomes, mixed regression models will be used including repeated measurements.Ethics and disseminationThe trial is performed in accordance with the Declaration of Helsinki. All patients must give informed consent prior to participation and the trial is initiated after approval by the Danish Data Protection Agency (P-2020-894) and the National Committee on Health Research Ethics (H-20066739). Positive, neutral and negative results of the trial will be published.Trial registration numberNCT04582734.
Databáze: OpenAIRE
Externí odkaz: